clinical-stage – Talk Bio

Third Harmonic Bio to Liquidate, Selling Key Urticaria Drug Asset THB335

1 week ago talkbio0Tagged biopharma exit strategy, Chronic Spontaneous Urticaria, clinical-stage, CSU, drug sales, Inhibitor, KIT, Kit device, shareholder, THB335, Third Harmonic Bio liquidation, value maximization

Third Harmonic Bio liquidation , THB335 drug sale , chronic spontaneous urticaria (CSU) , KIT inhibitor , biopharma exit strategy , clinical-stage biotech , shareholder value maximization

Arrowhead Shifts Focus to Obesity Development After Heart Disease Drug Clearance

8 months ago talkbio0Tagged Arrowhead, clinical-stage, development aspects, Heart Disease Drug, Obesity, preclinical assets

Arrowhead, obesity development, heart disease drug, biotech, pharmaceuticals, clinical-stage candidates, preclinical assets

Merck Acquires Clinical-Stage CD3xCD19 Bispecific Antibody for $700M

9 months ago talkbio0Tagged Antibodies, Bispecific, CD3xCD19, clinical-stage, Curon Biopharmaceutical, Merck, pharmaceutical acquisition

Merck, CD3xCD19 bispecific antibody, Curon Biopharmaceutical, clinical-stage, pharmaceutical acquisition

Valneva Invests $10M in LimmaTech for Clinical-Stage Shigella Vaccine

9 months ago talkbio0Tagged clinical-stage, development aspects, LimmaTech, Shigella Vaccines, Vaccines, Valneva

Valneva, LimmaTech, Shigella vaccine, clinical-stage, biotech, pharmaceuticals, vaccine development

Rapport Neuroscience Biotech Aims for Expansion with Initial Public Offering

11 months ago talkbio0Tagged clinical-stage, expansion, IPO, mental health, nervous system disorder, Neuroscience discipline, Rapport

Rapport, neuroscience, biotech, IPO, clinical-stage, expansion, pharmaceuticals, neurological disorders, mental health